Impact Of Clinical And Procedural Factors Upon C Reactive Protein Dynamics Following Transcatheter Aortic Valve Implantation

AIM: To determine the effect of procedural and clinical factors upon C reactive protein (CRP) dynamics following transcatheter aortic valve implantation (TAVI).METHODS: Two hundred and eight consecutive patients that underwent transfemoral TAVI at two hospitals (Imperial, College Healthcare NHS Trust, Hammersmith Hospital, London, United Kingdom and San Raffaele Scientific Institute, Milan, Italy) were included. Daily venous plasma CRP levels were measured for up to 7 d following the procedure (or up to discharge). Procedural factors and 30-d safety outcomes according to the Valve Academic Research Consortium 2 definition were collected.RESULTS: Following TAVI, CRP significantly increased reaching a peak on day 3 of 87.6 +/- 5.5 mg/dL, P < 0.001. Patients who developed clinical signs and symptoms of sepsis had significantly increased levels of CRP (P < 0.001). The presence of diabetes mellitus was associated with a significantly higher peak CRP level at day 3 (78.4 +/- 3.2 vs 92.2 +/- 4.4, P < 0.001). There was no difference in peak CRP release following balloon-expandable or self-expandable TAVI implantation (94.8 +/- 9.1 vs 81.9 +/- 6.9, P = 0.34) or if post-dilatation was required (86.9 +/- 6.3 vs 96.6 +/- 5.3, P = 0.42), however, when pre-TAVI balloon aortic valvuloplasty was performed this resulted in a significant increase in the peak CRP (110.1 +/- 8.9 vs 51.6 +/- 3.7, P < 0.001). The development of a major vascular complication did result in a significantly increased maximal CRP release (153.7 +/- 11.9 vs 83.3 +/- 7.4, P = 0.02) and there was a trend toward a higher peak CRP following major/life-threatening bleeding (113.2 +/- 9.3 vs 82.7 +/- 7.5, P = 0.12) although this did not reach statistical significance. CRP was not found to be a predictor of 30-d mortality on univariate analysis.CONCLUSION: Careful attention should be paid to baseline clinical characteristics and procedural factors when interpreting CRP following TAVI to determine their future management.